SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?


To: David Cathcart who wrote (646)2/11/1998 2:04:00 PM
From: Dan Lazare  Respond to of 1826
 
Thanks, David. The details of the report made very pleasant reading to me. Seems to have solid management. One step at a time.
Dan



To: David Cathcart who wrote (646)2/11/1998 2:22:00 PM
From: lrb  Read Replies (1) | Respond to of 1826
 
Anyone been to one of them-there "investor breakfasts" lately where
Blitzer shares the real scoop? I'm interested in:
- what's been learned in MGI 114 Phase I
- when he expects to receive approval for Sjogren's
- when he hopes to have a partner for MGI 114



To: David Cathcart who wrote (646)2/11/1998 4:18:00 PM
From: Vector1  Read Replies (1) | Respond to of 1826
 
David,
I couldn't pull up last qs press release. Do you remember what Salagen sales were last quarter. The quarter to quarter sequential increase does not look all that impressive.
V1